Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Intangibles (2020 - 2022)

Ovid Therapeutics' Intangibles history spans 3 years, with the latest figure at $244000.0 for Q1 2022.

  • For Q1 2022, Intangibles fell 7.22% year-over-year to $244000.0; the TTM value through Mar 2022 reached $244000.0, down 7.22%, while the annual FY2021 figure was $263000.0, 17.55% down from the prior year.
  • Intangibles reached $244000.0 in Q1 2022 per OVID's latest filing, down from $263000.0 in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $436000.0 in Q1 2020 to a low of $197000.0 in Q3 2021.
  • Average Intangibles over 3 years is $298444.4, with a median of $263000.0 recorded in 2021.
  • Peak YoY movement for Intangibles: plummeted 45.43% in 2021, then fell 7.22% in 2022.
  • A 3-year view of Intangibles shows it stood at $319000.0 in 2020, then dropped by 17.55% to $263000.0 in 2021, then dropped by 7.22% to $244000.0 in 2022.
  • Per Business Quant, the three most recent readings for OVID's Intangibles are $244000.0 (Q1 2022), $263000.0 (Q4 2021), and $197000.0 (Q3 2021).